Effects of Azithromycin Lactobionate in neonatal rats with hyperoxia induced lung injury

Meihua JIN,Zhengyong JIN
DOI: https://doi.org/10.16068/j.1000-1824.2015.03.010
2015-01-01
Abstract:OBJECTIVE To investigate the effects of Azithromycin Lactobionate in neonatal rats with hyperoxia induced lung injury.METHODSwistar neonatal rats were randomly into three groups.Air control group,hyperoxia injury group,Azithromycin Lactobionate treated group.Air control group was exposed to indoor air,and the rest were exposed to 85% O2 for 7days.24hour-old rats in treated group received intraperitoneal injection of Azithromycin Lactobionate(200mg/kg)per day,rats in air control group and hyperoxia injury group,received intraperitoneal injection of normal saline.At each time interval of 1,3and7 days after experiment,and ten rats in each group were executed.Pathological changes of lung were observed under a light microscope;by using western blotting method detected expression levels of Bcl2/Bax,caspase-12.RESULTSHE staining results:Azithromycin Lactobionate treated group of the lung tissue than the hyperoxia injury group,pathological changes were significantly reduced.Western blotting results showed that,when extended the time of hyperoxia,Bax expression were gradually increased;when extended the time of hyperoxia,the Bc12 expression were gradually reduced;when extended the time of hyperoxia,Bc12/Bax was gradually decreased;caspase-12 protein of hyperoxia group were upregulated,when the hyperoxia time extended,the protein content became higher,while there were no significant change in the hyperoxia for 1day group.Azithromycin Lactobionate treated group on the same days,which shows that the Azithromycin Lactobionate can inhibit the protein expressions.CONCLUSIONAzithromycin Lactobionate can reduce hyperoxia-induced lung edema and inflammatory response,and protective effects on lung injury induced by hyperoxia in neonatal rats.
What problem does this paper attempt to address?